Valvular Aortic Valve

Structural Heart Disease

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted...

Dr. Carlos Fava - 7 April, 2025

Coronary disease

Is Angioplasty Always Necessary after TAVR?

Courtesy of: Silvina E. Gomez, MD The prevalence of coronary artery disease (CAD) in patients undergoing TAVR is...

Silvina Gómez - 25 February, 2025

Structural heart disease

Asymptomatic Aortic Stenosis: A Complex Decision

Asymptomatic severe aortic stenosis continues to pose a significant challenge when it comes to clinical decision-making, often...

Dr. Carlos Fava - 31 December, 2024

Structural heart disease

TAVI and Aortic Regurgitation: Are All Valves the Same?

Aortic regurgitation (AR) accounts for 0.5- 2.2% of all cases of valve disease in individuals over 65...

Dr. Carlos Fava - 31 December, 2024

Structural heart disease

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with...

Dr. Carlos Fava - 24 December, 2024

Structural heart disease

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies...

Dr. Omar Tupayachi - 20 December, 2024

Other

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an...

Dr. Omar Tupayachi - 17 December, 2024

Structural heart disease

COMPARE TAVI: One-Year Results of a Randomized Study Comapring Two Balloon-Expandable Valves

The COMPARE TAVI organization conducted direct comparison of new transcatheter aortic valve implantation (TAVI) devices against contemporary...

Dr. Omar Tupayachi - 17 December, 2024

Valvular Aortic Valve

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

Is Angioplasty Always Necessary after TAVR?

Asymptomatic Aortic Stenosis: A Complex Decision

TAVI and Aortic Regurgitation: Are All Valves the Same?

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

COMPARE TAVI: One-Year Results of a Randomized Study Comapring Two Balloon-Expandable Valves

Últimas Noticias

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

Noticias Institucionales

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

Watch our event on Evidence and Controversies of Renal Denervation in 2025

Accesos